Download This PaperThe Future of Gene Patents and the Implications for Medicine
173 JAMA Internal Medicine 1569, Sept. 2013
2 Pages Posted: 15 Sep 2013 Last revised: 25 Sep 2013
Date Written: September 23, 2013
Abstract
The Supreme Court decision in Myriad Genetics struck down the patenting of human genomic DNA. What will this mean for genetic testing and medicine, more broadly?
Keywords: gene, genetic, patent, intellectual property, myriad, amp, medicine, BRCA, cancer
JEL Classification: K00, K11, O3, O34
Suggested Citation: Suggested Citation
Sherkow, Jacob S. and Greely, Henry (Hank) T., The Future of Gene Patents and the Implications for Medicine (September 23, 2013). 173 JAMA Internal Medicine 1569, Sept. 2013, Available at SSRN: https://ssrn.com/abstract=2325679
Jacob S. Sherkow (Contact Author)
University of Illinois College of Law ( email )
504 E. Pennsylvania Avenue
Champaign, IL 61820
United States
Henry (Hank) T. Greely
Stanford Law School ( email )
559 Nathan Abbott Way
Stanford, CA 94305-8610
United States
650-723-2517 (Phone)
650-725-0253 (Fax)
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.